Article

August 8, 2012

Meaningful Users Shouldn't be Held to Perfection: Work Group

When it comes to hitting meaningful-use targets, batting .800 ought to be good enough.

Read the full story: http://tinyurl.com/8z3yz8p

Source: ModernHealthcare.com

Members of a work group helping the federal government develop criteria for its electronic health-records incentive payment programs pondered how close to perfection providers should be pushed to be deemed “meaningful users” of EHRs and qualify for payment under the program created by the American Recovery and Reinvestment Act of 2009.

Related Videos

Harry Travis sitting for a video interview

Antoine Keller, MD

Dr K. Vish Viswanath

Lalan Wilfong, MD

Nini Wu, MD, MBA

Kathi Henson, MBA, sitting for a video interview

Mike Fazio, Navista, Cardinal Health

Dr K. Vish Viswanath

Julia Logan

Related Content

AJMC

May 14th 2025

Digital Health Implementation Among Older Adults: Health Technology Navigators’ Perspectives

Katarina Wang, BS Ann Marie Hernandez, MD, MPH Veronica Penate, BS Anshu Abhat, MD, MPH Alejandra Casillas, MD, MSHS

Health technology navigators share perspectives on barriers to and facilitators of digital health access for older, linguistically diverse patients in a Los Angeles safety-net system.

May 13th 2025

Inside the Center's MDD Value Model and Its Use of Dynamic Pricing

Brooke McCormick Larragem Raines, MS

Larragem Raines, MS, of the Center for Innovation & Value Research, discusses the organization's major depressive disorder (MDD) open-source value model, dynamic pricing, and the future role of artificial intelligence in care.

CAR NK cells | Image credit: MD Anderson

May 12th 2025

For Patients Who Cannot Wait, This Off-the-Shelf CAR NK Treatment for AML Leaves Healthy Cells Alone

Stephen Strickland, MD, MSCI Interview by Mary Caffrey

First part of a 2-part interview with Stephen Strickland, MD, MSCI, director of leukemia research for Sarah Cannon Research Institute. Strickland recently presented data from a phase 1 trial of SENTI-202, an investigational chimeric antigen receptor (CAR) natural killer (NK) cell therapy.

Managed Care Cast Presents: Unlocking the Potential of CGM Technology

April 10th 2025

Managed Care Cast Presents: Unlocking the Potential of CGM Technology

Laura Joszt, MA

A group of experts discusses the use of continuous glucose monitoring (CGM) technology in diabetes and its transformative potential in managing the disease.

AJMC

May 9th 2025

Predictive Models for Low Birth Weight: A Comparative Analysis of Algorithmic Fairness–Improving Approaches

Clare C. Brown, PhD, MPH Horacio Gomez-Acevedo, PhD Benjamin C. Amick III, PhD J. Mick Tilford, PhD Keneshia Bryant-Moore, PhD, APRN Michael Thomsen, PhD

This study compared 6 algorithmic fairness–improving approaches for low-birth-weight predictive models and found that they improved accuracy but decreased sensitivity for Black populations.

Effect of Remote Patient Monitoring on Stage 2 Hypertension

May 6th 2025

Effect of Remote Patient Monitoring on Stage 2 Hypertension

Lyle Dennis, MD Irina Koyfman, DNP, NP-C, RN

A community-based remote patient monitoring (RPM) program was associated with significant reduction in blood pressure in Medicare patients with stage 2 hypertension, highlighting the potential benefits of RPM with care coaching.

Related Content

AJMC

May 14th 2025

Digital Health Implementation Among Older Adults: Health Technology Navigators’ Perspectives

Katarina Wang, BS Ann Marie Hernandez, MD, MPH Veronica Penate, BS Anshu Abhat, MD, MPH Alejandra Casillas, MD, MSHS

Health technology navigators share perspectives on barriers to and facilitators of digital health access for older, linguistically diverse patients in a Los Angeles safety-net system.

May 13th 2025

Inside the Center's MDD Value Model and Its Use of Dynamic Pricing

Brooke McCormick Larragem Raines, MS

Larragem Raines, MS, of the Center for Innovation & Value Research, discusses the organization's major depressive disorder (MDD) open-source value model, dynamic pricing, and the future role of artificial intelligence in care.

CAR NK cells | Image credit: MD Anderson

May 12th 2025

For Patients Who Cannot Wait, This Off-the-Shelf CAR NK Treatment for AML Leaves Healthy Cells Alone

Stephen Strickland, MD, MSCI Interview by Mary Caffrey

First part of a 2-part interview with Stephen Strickland, MD, MSCI, director of leukemia research for Sarah Cannon Research Institute. Strickland recently presented data from a phase 1 trial of SENTI-202, an investigational chimeric antigen receptor (CAR) natural killer (NK) cell therapy.

Managed Care Cast Presents: Unlocking the Potential of CGM Technology

April 10th 2025

Managed Care Cast Presents: Unlocking the Potential of CGM Technology

Laura Joszt, MA

A group of experts discusses the use of continuous glucose monitoring (CGM) technology in diabetes and its transformative potential in managing the disease.

AJMC

May 9th 2025

Predictive Models for Low Birth Weight: A Comparative Analysis of Algorithmic Fairness–Improving Approaches

Clare C. Brown, PhD, MPH Horacio Gomez-Acevedo, PhD Benjamin C. Amick III, PhD J. Mick Tilford, PhD Keneshia Bryant-Moore, PhD, APRN Michael Thomsen, PhD

This study compared 6 algorithmic fairness–improving approaches for low-birth-weight predictive models and found that they improved accuracy but decreased sensitivity for Black populations.

Effect of Remote Patient Monitoring on Stage 2 Hypertension

May 6th 2025

Effect of Remote Patient Monitoring on Stage 2 Hypertension

Lyle Dennis, MD Irina Koyfman, DNP, NP-C, RN

A community-based remote patient monitoring (RPM) program was associated with significant reduction in blood pressure in Medicare patients with stage 2 hypertension, highlighting the potential benefits of RPM with care coaching.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions